Materials • Major Chemicals
$101.41 ▲ +0.71
(+0.71%)
MKT CAP: $2.50B • VOL: 205.1K
52W L $66 52W H $102
IOSP // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $1.78B | $1.85B | $1.95B |
| YoY Revenue Growth % | -3.7% | -5.3% | — |
| Gross Profit | $492.4M | $542.9M | — |
| Gross Margin % | 27.7% | 29.4% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $129.5M | $177.9M | $161.6M |
| Operating Margin % | 7.3% | 9.6% | 8.3% |
| Net Income (GAAP) | $0 | $0 | $0 |
| EBITDA (Normalized) | — | — | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $138.3M | $184.5M | $207.3M |
| Capital Expenditures (CapEx) | — | — | — |
| Free Cash Flow (FCF) | $138.3M | $184.5M | $207.3M |
| FCF Margin % | 7.8% | 10.0% | 10.6% |
| Return on Invested Capital (ROIC %) | 9.9% | 15.2% | — |
| Cash & Short-Term Equivalents | $292.5M | $289.2M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $1.33B | $1.21B | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR IOSP.